SpringWorks Therapeutics Eulerpool Novinky

SpringWorks Therapeutics Novinky o akciích

SpringWorks Therapeutics je sledován mnoha novináři a investory po celém světě. Nejaktuálnější SpringWorks Therapeutics zprávy shromažďujeme zde.

• 19. srpna ·

  Yahoo
  Merck announces EC approval of Ogsiveo for desmoid tumours
• 18. srpna ·

  Yahoo
  European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
• 15. srpna ·

  Yahoo
  Merck KGaA ventures into new territory in the US
• 18. července ·

  Yahoo
  European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
• 2. července ·

  Yahoo
  Merck concludes SpringWorks acquisition for $3.4bn
• 1. července ·

  Yahoo
  Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
• 20. června ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
• 28. května ·

  SeekingAlpha
  Carillon Eagle Small Cap Growth Fund Q1 2025 Commentary
• 27. května ·

  Yahoo
  High Growth Tech Stocks in the US to Watch This May 2025
• 23. května ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN